Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-024078

Chief Business Officer sold 50,000 shares at $45.96 ($2,297,755)

  • Chief Business Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meyer Andrew Hollman Chief Business Officer 2024-09-27 Option exercise +50,000 $4.21 $210,500 117,592 D
Meyer Andrew Hollman Chief Business Officer 2024-09-27 Sale −50,000 $45.96 $2,297,755 67,592 D
Derivatives
Meyer Andrew Hollman Chief Business Officer 2024-09-27 Option exercise · Stock Option (right to buy) −50,000 100,667 D
Open-market sales · 50,000 sh · avg $45.96 · $2,297,755
Loading xslF345X05/form4-09272024_110955.xml…